Status:
COMPLETED
Efficacy and Safety of Monotherapy With Noradrenaline and Terlipressin in Patients of Cirrhosis With Septic Shock Admitted to Intensive Care Unit
Lead Sponsor:
Institute of Liver and Biliary Sciences, India
Conditions:
Cirrhosis With Septic Shock
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The Patient evaluated in Emergency room since admission and detailed history and clinical examination done .The in hospital cases where sepsis is the culprit and shifted to Intensive Care Unit (ICU) i...
Eligibility Criteria
Inclusion
- Patient of cirrhosis or ACLF (Acute on Chronic Liver Failure) with septic shock (defined later).
- Age 18-70yrs
- An informed consent from the patient or relative
Exclusion
- Pronounced cardiac dysfunction( valvular heart disease, coronary artery disease),
- Acute mesenteric ischemia (confirmed or suspected) or vasospastic diathesis (e.g. Reynaud's syndrome or related diseases).
- Pregnancy
- Previous history of transplantation on immunosuppressant.
- Acute gastrointestinal bleed.(defined later)
Key Trial Info
Start Date :
October 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT01836224
Start Date
October 1 2012
End Date
September 1 2014
Last Update
November 22 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of liver and Biliary Sciences
New Delhi, National Capital Territory of Delhi, India, 110070